{"filing":{"accession_number":"0001035267-26-000042","cik":"0001035267","ticker":"ISRG","company_name":"INTUITIVE SURGICAL INC","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"isrg-20260528.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000042/isrg-20260528.htm"},"events":[{"id":8331,"run_id":7315,"accession_number":"0001035267-26-000042","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Taylor Patton's appointment as Chief Commercial and Marketing Officer is the principal disclosed action. While Henry L. Charlton's transition to a different senior role is also mentioned, the filing centers on the succession event—Patton succeeding Charlton in a C-suite commercial leadership position. This executive appointment at a major medical device company is material to investors assessing management continuity and strategic direction.","company_name":"INTUITIVE SURGICAL INC","ticker":"ISRG","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":2183,"accession_number":"0001035267-26-000042","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Taylor Patton's appointment as Chief Commercial and Marketing Officer is the principal disclosed action. While Henry L. Charlton's transition to a different senior role is also mentioned, the filing centers on the succession event—Patton succeeding Charlton in a C-suite commercial leadership position. This executive appointment at a major medical device company is material to investors assessing management continuity and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:13:28.080029+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2183,"accession_number":"0001035267-26-000042","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Taylor Patton's appointment as Chief Commercial and Marketing Officer is the principal disclosed action. While Henry L. Charlton's transition to a different senior role is also mentioned, the filing centers on the succession event—Patton succeeding Charlton in a C-suite commercial leadership position. This executive appointment at a major medical device company is material to investors assessing management continuity and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:13:28.080029+00:00","company_name":"INTUITIVE SURGICAL INC","ticker":"ISRG","filing_date":"2026-05-28"}]}